Legend Biotech Corp Net Asset Quality Index
Legend Biotech Corp net asset quality index. Legend Biotech Corp (LEGN) has a Net Asset Quality Index of 70.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.75 Billion minus total liabilities of $521.32 Million yields net assets of $1.23 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Legend Biotech Corp (LEGN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Legend Biotech Corp (2017–2025)
Net asset quality index of Legend Biotech Corp from 2017 to 2025. This chart shows how Legend Biotech Corp's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 70.2%, representing net assets of $1.23 Billion against total assets of $1.75 Billion USD. See Legend Biotech Corp (LEGN) shareholders funds for net asset value and shareholders' equity analysis.
Legend Biotech Corp Net Asset Quality Index by Year (2017–2025)
Legend Biotech Corp net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Legend Biotech Corp from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see LEGN stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 57.8% | $1.00 Billion | $1.73 Billion | $731.60 Million | ▼ -4.5 pp |
| 2024 | 62.3% | $1.04 Billion | $1.67 Billion | $629.61 Million | ▼ -5.4 pp |
| 2023 | 67.7% | $1.25 Billion | $1.85 Billion | $597.24 Million | ▲ +11.8 pp |
| 2022 | 55.9% | $744.31 Million | $1.33 Billion | $586.65 Million | ▼ -12.5 pp |
| 2021 | 68.4% | $765.94 Million | $1.12 Billion | $353.52 Million | ▼ -14.6 pp |
| 2020 | 83.1% | $599.82 Million | $722.09 Million | $122.27 Million | ▲ +125.8 pp |
| 2019 | -42.7% | $-122.87 Million | $287.71 Million | $410.58 Million | ▼ -44.7 pp |
| 2018 | 2.0% | $8.65 Million | $429.05 Million | $420.40 Million | ▼ -3.1 pp |
| 2017 | 5.1% | $12.17 Million | $238.69 Million | $226.53 Million | — |